Oral oncolytic and antiretroviral therapy administration: dose adjustments, drug interactions, and other considerations for clinical use

Oral oncolytic and antiretroviral therapy administration: dose adjustments, drug interactions, and other considerations for clinical use

The rise in non-AIDS defining cancers (NADCs) is emerging as a leading cause of death for HIV and cancer patients. To address this, current literature and guidelines suggest the continuation of antiretroviral therapy (ART) with oral oncolytic agents to prevent adverse complications associated with H...

Full description

Bibliographic Details
Main Authors: Melissa E Badowski, Bradley Burton, Kristy M Shaeer, John Dicristofano
Format: Article
Language:English
Published: BioExcel Publishing Ltd 2019-02-01
Series:Drugs in Context
Subjects:
adverse events
antiretroviral therapy
antiretrovirals
cancer
dosage adjustments
drug–drug interactions
HIV/AIDS
oral oncology agents
oral oncolytics
Online Access:https://www.drugsincontext.com/oral-oncolytic-and-antiretroviral-therapy-administration:-dose-adjustments,-drug-interactions,-and-other-considerations-for-clinical-use

Internet

https://www.drugsincontext.com/oral-oncolytic-and-antiretroviral-therapy-administration:-dose-adjustments,-drug-interactions,-and-other-considerations-for-clinical-use

Similar Items